ProSpecBio, an evolving biotech company dedicated to providing highly purified proteins to the global research community, today announced the launch of its latest product: CHO cell–derived recombinant ...

An international team of scientists has generated a new ring-shaped protein nanomaterial capable of strongly binding to and ...

Protalix BioTherapeutics, Inc. (NYSEAMERICAN:PLX) is among the hidden penny stocks to buy now. During the first quarter, Goldman Sachs Group Inc. expanded its holdings in Protalix BioTherapeutics, Inc ...

GC Biopharma (006280.KS), a South Korean biopharmaceutical company, announced today that it has signed an agreement with Curevo Vaccine to secure contract manufacturing (CMO) rights for amezosvatein ...

Programmable proteins designed with Boolean logic gates may improve targeted drug delivery precision and scalability, ...

In this GEN webinar, our expert speaker(s) will share real-world experiences and strategies for improving product recovery and consistency during downstream processing.

The Europe API market is driven by increasing demand for generics and specialty medicines due to patent expirations and ...

Alzheimer's disease (AD) is a major global public health concern. Although monoclonal antibody medicines targeting beta-amyloid (Aβ) have achieved approval, there is still an urgent and unmet need for ...

Openwater has developed a low-intensity focused ultrasound device that might one day noninvasively disrupt microclots in long ...

Pove is an investigational recombinant fusion protein therapeutic and dual antagonist of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines with best-in-class ...

A new study reveals that the protein Reelin may hold the key to treating both “leaky gut” and major depressive disorder.